CNMD - These Analysts Revise Their Forecasts On CONMED After Q4 Results | Benzinga
CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday.
Conmed posted adjusted earnings of $1.06 per shares, missing market estimates of $1.11 per share. The company’s quarterly sales came in at $327.05 million versus expectations of $332.20 million, according to data from Benzinga Pro.
Domestic revenue surged 33.3% year-over-year during the quarter, while international revenue rose 26.5% year-over-year as reported and 29.0% in constant currency.
"2023 was a great year for CONMED, and I am proud that our global business delivered record revenue in both the fourth quarter and for the full year," commented Curt R. Hartman, CONMED’s Chair ...